Cancer cost profiles: The Epicost estimation approach

Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic bur...

Full description

Bibliographic Details
Main Authors: Silvia Francisci, Guilia Capodaglio, Anna Gigli, Cristina Mollica, Stefano Guzzinati
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.974505/full
_version_ 1811271836982312960
author Silvia Francisci
Guilia Capodaglio
Anna Gigli
Cristina Mollica
Stefano Guzzinati
author_facet Silvia Francisci
Guilia Capodaglio
Anna Gigli
Cristina Mollica
Stefano Guzzinati
author_sort Silvia Francisci
collection DOAJ
description Sustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope of this paper is to illustrate a novel comprehensive approach (called Epicost) to the estimation of the economic burden of cancer, based on micro-data collected from multiple data sources. It consists of a model of cost analysis to estimate the amount of reimbursement payed by the National Health Service to health service providers (hospitals, ambulatories, pharmacies) for the expenses incurred in the diagnoses and treatments of a cohort of cancer patients; these cancer costs are estimated in various phases of the disease reflecting patients' patterns of care: initial, monitoring and final phase. The main methodological features are illustrated using a cohort of colon cancer cases from a Cancer Registry in Italy. This approach has been successfully implemented in Italy and it has been adapted to other European countries, such as Belgium, Norway and Poland in the framework of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, sponsored by the European Commission. It is replicable in countries/regions where population-based cancer registry data is available and linkable at individual level with administrative data on costs of care.
first_indexed 2024-04-12T22:28:15Z
format Article
id doaj.art-5a6de2f408674addb80f2e3501d70617
institution Directory Open Access Journal
issn 2296-2565
language English
last_indexed 2024-04-12T22:28:15Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj.art-5a6de2f408674addb80f2e3501d706172022-12-22T03:14:03ZengFrontiers Media S.A.Frontiers in Public Health2296-25652022-09-011010.3389/fpubh.2022.974505974505Cancer cost profiles: The Epicost estimation approachSilvia Francisci0Guilia Capodaglio1Anna Gigli2Cristina Mollica3Stefano Guzzinati4National Centre for Disease Prevention and Health Promotion, National Health Institute, Rome, ItalyScreening and Health Impact Assessment Unit, Azienda Zero, Padova, ItalyInstitute for Research on Population and Social Policies, National Research Council, Rome, ItalyDepartment of Statistical Sciences, Sapienza University of Rome, Rome, ItalyRegional Epidemiological Service, Veneto Cancer Registry (RTV), Azienda Zero, Padova, ItalySustainability of cancer burden is becoming increasingly central in the policy makers' debate, and poses a challenge for the welfare systems, due to trends towards greater intensity of healthcare service use, which imply increasing costs of cancer care. Measuring and projecting the economic burden associated with cancer and identifying effective policies for minimising its impact are important issues for healthcare systems. Scope of this paper is to illustrate a novel comprehensive approach (called Epicost) to the estimation of the economic burden of cancer, based on micro-data collected from multiple data sources. It consists of a model of cost analysis to estimate the amount of reimbursement payed by the National Health Service to health service providers (hospitals, ambulatories, pharmacies) for the expenses incurred in the diagnoses and treatments of a cohort of cancer patients; these cancer costs are estimated in various phases of the disease reflecting patients' patterns of care: initial, monitoring and final phase. The main methodological features are illustrated using a cohort of colon cancer cases from a Cancer Registry in Italy. This approach has been successfully implemented in Italy and it has been adapted to other European countries, such as Belgium, Norway and Poland in the framework of the Innovative Partnership for Action Against Cancer (iPAAC) Joint Action, sponsored by the European Commission. It is replicable in countries/regions where population-based cancer registry data is available and linkable at individual level with administrative data on costs of care.https://www.frontiersin.org/articles/10.3389/fpubh.2022.974505/fullcancer epidemiologycancer cost evaluationcancer prevalence by phase of carecancer registryadministrative data sources
spellingShingle Silvia Francisci
Guilia Capodaglio
Anna Gigli
Cristina Mollica
Stefano Guzzinati
Cancer cost profiles: The Epicost estimation approach
Frontiers in Public Health
cancer epidemiology
cancer cost evaluation
cancer prevalence by phase of care
cancer registry
administrative data sources
title Cancer cost profiles: The Epicost estimation approach
title_full Cancer cost profiles: The Epicost estimation approach
title_fullStr Cancer cost profiles: The Epicost estimation approach
title_full_unstemmed Cancer cost profiles: The Epicost estimation approach
title_short Cancer cost profiles: The Epicost estimation approach
title_sort cancer cost profiles the epicost estimation approach
topic cancer epidemiology
cancer cost evaluation
cancer prevalence by phase of care
cancer registry
administrative data sources
url https://www.frontiersin.org/articles/10.3389/fpubh.2022.974505/full
work_keys_str_mv AT silviafrancisci cancercostprofilestheepicostestimationapproach
AT guiliacapodaglio cancercostprofilestheepicostestimationapproach
AT annagigli cancercostprofilestheepicostestimationapproach
AT cristinamollica cancercostprofilestheepicostestimationapproach
AT stefanoguzzinati cancercostprofilestheepicostestimationapproach